Free Trial

Cumberland Pharmaceuticals (CPIX) SEC Filings & 10K Form

Cumberland Pharmaceuticals logo
$4.41 +0.28 (+6.78%)
Closing price 03/28/2025 04:00 PM Eastern
Extended Trading
$4.34 -0.08 (-1.70%)
As of 03/28/2025 07:13 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Cumberland Pharmaceuticals SEC Filings

DateFilerForm TypeView
03/19/2025
4:07 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2025
4:30 PM
Cumberland Pharmaceuticals (Filer)
Form ARS
03/18/2025
4:11 PM
Bitterman Chris T. (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:11 PM
Cumberland Pharmaceuticals (Issuer)
Herman James L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:12 PM
Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:13 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:14 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:15 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:15 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:06 PM
Cumberland Pharmaceuticals (Issuer)
Hamm John M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:09 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
4:10 PM
Anthony Todd M. (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
4:00 PM
Cumberland Pharmaceuticals (Filer)
Form DEF 14A
03/10/2025
4:01 PM
Cumberland Pharmaceuticals (Filer)
Form DEFA14A
03/07/2025
4:15 PM
Cumberland Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
4:26 PM
Cumberland Pharmaceuticals (Subject)
KAZIMI A J (Filed by)
Form SCHEDULE 13G
02/04/2025
3:37 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2025
3:38 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4/A
01/30/2025
3:39 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4/A
01/30/2025
3:39 PM
Cumberland Pharmaceuticals (Issuer)
Galante Joseph C (Reporting)
Form 4/A
01/30/2025
3:40 PM
Brown Martin S JR (Reporting)
Cumberland Pharmaceuticals (Issuer)
Form 4/A
12/30/2024
6:41 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:44 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:45 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/30/2024
6:47 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/09/2024
4:04 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/05/2024
4:02 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:03 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:04 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2024
4:05 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:04 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/07/2024
4:09 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
4:12 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/05/2024
3:38 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:39 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
3:39 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/04/2024
4:15 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/03/2024
3:06 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:07 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:08 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
10:31 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Has Trump finally met his match? (Ad)

Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance to walk away with gains as high as 235%, 459%, and 700% - all while the stock market got cut in half. Could he be right again?

Click here for his emergency broadcast...
09/05/2024
9:42 AM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
5:29 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:40 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/04/2024
4:42 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
4:07 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/02/2024
4:33 PM
Cumberland Pharmaceuticals (Issuer)
Young Caroline (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:31 PM
Cumberland Pharmaceuticals (Issuer)
KAZIMI A J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:32 PM
Cumberland Pharmaceuticals (Issuer)
Jones James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
4:32 PM
Cumberland Pharmaceuticals (Issuer)
Krogulski Kenneth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
3:37 PM
Cumberland Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/07/2024
4:14 PM
Cumberland Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools


This page (NASDAQ:CPIX) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners